Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00746265 · ClinicalTrials.gov registry record · NA

Behavioral Treatment for Weight Loss

A NA study of Overweight and Obesity, sponsored by Drexel University.

Completed
Registry status
NA
Development phase
128
Enrollment target
1
Study location

NCT00746265: Completed NA study of Overweight and Obesity, sponsored by Drexel University.

NCT00746265 is a NA study of Overweight and Obesity that has completed, run by Drexel University. The registered enrollment target is 128 participants, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00746265, a NA study of Overweight and Obesity, has completed, sponsored by Drexel University.

COMPLETED
Registry status
NA
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

This project compares gold standard cognitive-behavioral therapy (based on LEARN, Diabetes Prevention Program, LOOK Ahead) used in both research and clinical settings, with acceptance-based behavioral therapy for weight loss. Standard behavior treatment (SBT) focuses on modifying eating, thinking, and activity levels. Participants limit their daily caloric intake, keep food records, increase physical activity, and practice weight control behaviors, such as stimulus control, cognitive restructuring, alternative coping skills, and distinguishing hunger from cravings. The acceptance-based approach (ABT) incorporates the behavioral and nutritional components, but replaced the cognitive and motivational components with components that are consistent with an acceptance-based approach, such as acceptance and willingness to experience cravings, cognitive defusion, mindfulness training to interrupt automatic eating, and values work. These components are drawn from Acceptance and Commitment Therapy (ACT; Hayes, Strosahl, \& Wilson, 1999), a cognitive-behavioral therapy that has been gaining increasing attention and empirical support (Bach \& Hayes, 2002; Bond \& Bunce, 2000; Hayes et al. 2004). Though relatively new, acceptance-based strategies have demonstrated effectiveness in helping individuals to respond to unwanted thoughts and feelings (Hayes, Rissett, Korn, Zettle, Rosenfarb, Cooper, \& Grundt, 1999, Keogh, Bond, Hanmer, \& Tilston, 2005) and offer a novel alternative to control-based strategies (such as distraction and confrontation). Participants in this study will be randomly assigned to either the traditional behavioral therapy condition (SBT) or the acceptance-based behavioral therapy condition (ABT). Both conditions are delivered in group format. A total of 30, 75 minute sessions will take place over the course of 40 weeks. Specific Aims 1. To evaluate the feasibility and acceptability of the treatment, and its short and moderate-term effectiveness relative t

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral weight loss intervention

Study Locations (1)

Pennsylvania

  • Drexel University, Department of Psychology, 245 N. 15th Street, MS 626 - Philadelphia

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2008-09
Est. Completion 2012-06
Phase NA
Drexel University

92 total trials

What the finished NCT00746265 record still lists

NCT00746265 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (44% lower).

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 1 intervention - of which Behavioral weight loss intervention is the first listed.

NCT00746265 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00746265 about?

NCT00746265 is a clinical study titled "Behavioral Treatment for Weight Loss". This project compares gold standard cognitive-behavioral therapy (based on LEARN, Diabetes Prevention Program, LOOK Ahead) used in both research and clinical settings, with acceptance-based behavioral therapy for weight loss. Standard behavior treatment (SBT) focuses on modifying eating, thinking, a...

What is the current status of trial NCT00746265?

This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2008-09. Estimated completion is 2012-06.

What conditions does trial NCT00746265 study?

This clinical trial studies the following conditions: Overweight and Obesity.

What interventions are being tested in trial NCT00746265?

The interventions under investigation include: Behavioral weight loss intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00746265?

This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00746265 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00746265's enrollment target sits among peer trials

128 48th of 115 higher than 67 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00746265, the US trial registry maintained by the National Library of Medicine. NCT00746265 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.